Sponsor Collaborators Module

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Sponsor Collaborators Module

The Sponsor Collaborators Module contains information about the sponsors and collaborators involved in the clinical trial. This includes lead sponsor details, responsible party information, investigator information, and collaborator organizations that are supporting or conducting the study.

Sponsor Collaborators Module path is as follows:

Study -> Protocol Section -> Sponsor Collaborators Module -> Collaborators

Sponsor Collaborators Module

Ignite Creation Date: 2025-12-24 @ 10:04 PM
Ignite Modification Date: 2025-12-25 @ 7:40 PM
NCT ID: NCT04191135
Responsible Party Type: SPONSOR
Study: NCT04191135
Study Brief: Study of Olaparib Plus Pembrolizumab Versus Chemotherapy Plus Pembrolizumab After Induction With First-Line Chemotherapy Plus Pembrolizumab in Triple Negative Breast Cancer (TNBC) (MK-7339-009/KEYLYNK-009)
Protocol Section: NCT04191135
Collaborators (If Any):